$PMN
ProMIS Neurosciences Inc. Common Shares (ON)
XNAS•Health Care•Pharmaceutical Preparations
$3.77
▼-65.97%-$7.31
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateProMIS Neurosciences Inc. Common Shares (ON)
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $8.44 at 11:01 AM on Oct 27, then ran to $10.28 +22% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is PMN down today? It is at $3.77 (-65.97%), and our scanner flagged it 44 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PMN spikes, and full due diligence on PMN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PMN 44 times in the last 30 days. Create a free account to track $PMN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PMN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on PMN today, peaking at 40.2x its normal volume. Trading was halted for volatility today, which usually marks a fast, sharp move. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate HighlightsReported The second quarter ended with $53.4 million in cash and short-term investments, which is expected to fund operations through 2027, beyond the Company’s anticipated 12-month topline PRECISE-AD readout expected in the first quarter of 2027.Reported had been dosed for at least six months, 78% for at least nine months, and 49% had completed the full 12 months of dosing., from an SEC filing. Read it →Latest filing4Ownership documentOct 6, 2026 · 24 days agoThe company is cleared to issue new shares on demand, but has not yet. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kaplan Johanne Officer | Bought (open market) | +2K 0.03% of company | added 58% | 6K | $30K at $13.30 | Aug 5, 26 |
Kirwin Patrick D. Director | Bought (open market) | +4K 0.04% of company | added 100% | 5K | $45K at $11.33 | Apr 22, 26 |
Williams Eugene Director | Bought (open market) | +2K 0.02% of company | added 19% | 12K | $49K at $24.40 | Mar 5, 26 |
Williams Eugene Director | Bought (open market) | +2K 0.02% of company | added 24% | 10K | $48K at $24.00 | Mar 4, 26 |
Williams Eugene Director | Bought (open market) | +1K 0.01% of company | added 14% | 8K | $22K at $21.89 | Mar 3, 26 |
Williams Eugene Director | Bought (open market) | +1K 0.01% of company | added 16% | 7K | $23K at $22.53 | Mar 2, 26 |
Kaplan Johanne Officer | Bought (open market) | +2K 0.02% of company | added 70% | 4K | $25K at $15.35 | Feb 19, 26 |
Abg Management Ltd. Beneficial Owner (10%) | Bought (open market) | +701K 7.8% of company | added 100% | 943K | $8.5M at $12.13 | Feb 3, 26 |
Kirwin Patrick D. Director | Acquired (grant/award) | +3K 0.03% of company | added 100% | 5K | $37K at $12.13 | Feb 3, 26 |
Milbury Max A. Other | Acquired (grant/award) | +7K 0.07% of company | added 100% | 8K | $80K at $12.13 | Feb 3, 26 |
Warma Neil K Officer | Acquired (grant/award) | +6K 0.07% of company | n/a | 6K | $75K at $12.13 | Feb 3, 26 |
Kaplan Johanne Officer | Acquired (grant/award) | +2K 0.02% of company | added 100% | 2K | $25K at $12.13 | Feb 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
PMN is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on PMN today, peaking at 40.2x its normal volume. Trading was halted for volatility today, which usually marks a fast, sharp move. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
PMN last traded at $3.77, down 65.97% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is next expected to report earnings on Wednesday, November 11, 2026, about 12 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PMN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PMN 44 times in the last 30 days.
PMN (ProMIS Neurosciences Inc. Common Shares (ON)) trades on XNAS, with a market cap of about $30M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PMN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PMN discussion
Sign in to ask a question or join the discussion.